Description
The IVD Market in South Korea
The IVD Market in South Korea provides an overview of the in vitro diagnostics market in South Korea and its influences. The focus is on the following IVD market sub-segments: clinical chemistry, immunoassays, microbiology and molecular testing, point-of-care testing, and histology/cytology. The market data provided give an overview of developments in the in vitro diagnostics industry in South Korea, presenting IVD revenues by extracted market segment for 2017 and 2022, which includes general chemistry, blood gas analysis, urinalysis, infectious disease immunoassays, other immunoassays, blood bank screening immunoassays, POC glucose, POC other, ID/AST, microbiology molecular, HPV, CTC, other histology, and others.
The report provides South Korea in vitro diagnostic revenues by broad market segments for 2017 and 2022, comprising clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC), and histology. Also included in the report are trends influencing the industry and country-level data, including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences.
Table of Contents
CHAPTER 1: EXECUTIVE SUMMARY
INDUSTRY OVERVIEW
SCOPE AND METHODOLOGY
SOUTH KOREA IVD MARKET SUMMARY
Figure 1-1: South Korea In Vitro Diagnostic Sales by Market Segment, 2017-2022 ($ millions)
CHAPTER 2: SOUTH KOREA OVERVIEW
POPULATION
Table 2-1: Total Midyear Population by Broad Age Group: South Korea (million persons), 2010-2050
Figure 2-1: Total Midyear Population by Broad Age Group: South Korea (million persons), 2010-2050
Figure 2-2: Total Number of Births in South Korea by Year, 1990-2010 and Forecast 2020-2050
Figure 2-3: South Korea Life Expectancy at Birth in Years, 2010-2050
HEALTH INDICATORS
General Health
Disease Profiles in South Korea
Table 2-2: Top 5 Cancers Affecting South Korean Population (ranked by total number of cases), 2008-2015
ECONOMY AND HEALTH SPENDING
Figure 2-4: South Korea GDP, GDP (PPP) and Health Spending, 1990-2015 (billions of $)
Figure 2-5: South Korea Distribution of Income or Consumption by Quintile, 2007-2012
HEALTH INFRASTRUCTURE
Medical Facilities
Figure 2-6: South Korea JCI-Accredited Facilities, 2000-2018
Figure 2-7: Hospital Bed Density per 1,000 Population by Country, 2017 Estimates
Physicians
Figure 2-8: Physician Density per 1,000 Population by Country, 2017 Estimates
Medical Device Regulation
Table 2-3: Market Divers and Inhibitors for Entering South Korea’s Medical Device Market
CHAPTER 3: IVD MARKETS IN SOUTH KOREA
MARKET SUMMARY
The IVD Market in South Korea
Table 3-1: South Korea In Vitro Diagnostic Sales by Extracted Market Segment, 2017-2022 (General Chemistry, Blood Gas Analysis, Urinalysis, Infectious Disease Immunoassays, Other Immunoassays, Blood Bank Screening Immunoassays, POC Glucose, POC Other, ID/AST, Microbiology Molecular, HPV, CTC, Other Histology, Others, Total) ($ millions)
Figure 3-1: South Korea In Vitro Diagnostic Sales by Broad Market Segment, 2017-2022 (Histology, Microbiology, Clinical Chemistry, Immunoassay, POC, Other) ($ millions)
Figure 3-2: South Korea In Vitro Diagnostic Sales by Broad Market Segment, 2017 Market Distribution (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other) (%)
CLINICAL CHEMISTRY
Figure 3-3: South Korea – Clinical Chemistry Market (General Chemistries, Blood Gas Analysis, Urinalysis), 2017-2022
IMMUNOASSAY
Figure 3-4: South Korea – Immunoassay Market Value by Segment (Infectious Disease, Other Diseases, Blood Bank Screening), 2017-222
MICROBIOLOGY/MOLECULAR
Figure 3-5: South Korea Microbiology/Molecular Testing Market Value by Segment (ID/AST, Molecular), 2017-2022
POINT-OF-CARE
Figure 3-6: South Korea POC Market Value by Segment (Glucose, Infectious Disease, Other), 2017-2022
HISTOLOGY
Figure 3-7: South Korea – Histology Market (HPV, CTC, Others), 2017-2022
